NIKKEI 225
38,855.37 -44.65 (-0.11%) HANG SENG
18,821.16 -6.19 (-0.03%) CRUDE OIL
79.68 +1.96 (+2.52%) GOLD FUTURES
2,357.70 +23.20 (+0.99%) DOW
38,796.45 -273.14 (-0.70%) Bitcoin GBP
53,090.41 -1,842.23 (-3.35%)
NVO Jun 2024 175.000 call
- Zacks
Is Trending Stock Novo Nordisk A/S (NVO) a Buy Now?
Zacks.com users have recently been watching Novo Nordisk (NVO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- Fool.co.uk
8 stocks that Fools have been buying!
Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks. The post 8 stocks that Fools have been buying! appeared first on The Motley Fool UK.
- Reuters
Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows
As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible wider usage and a growing number of would-be rivals are leading some experts to raise annual global sales forecasts for the treatments to about $150 billion by the early 2030s. "It is very unusual to have a medicine that is capturing the imagination of millions of people," said Michael Kleinrock, senior research director at healthcare analytics firm IQVIA Institute for Data Science. Most insurers do not cover the new therapies with low co-payments, but an unprecedented percentage of people are paying themselves or with coupons from drug manufacturers, he said.
